The advanced wound care market is shifting towards innovative solutions like sensor-based wearables, AI tools, and bioengineered skin substitutes, emphasizing early detection and remote monitoring.
Nurses are playing a leading role in the assessment and treatment of wound care in general practice, according to a new ...
Mölnlycke Health Care, which makes bandages and wound dressings used in hospitals and acute care facilities, expects to complete the 78,000-square-foot factory expansion at the Brunswick Landing ...
The fully enrolled 594 patient second Phase 3 trial is a prospective, double-blind, multicenter, saline-controlled, parallel group, RCT of ReNu ASA, for the treatment of subjects with mild to severe ...
Opinion
16hOpinion
Philadelphia sets standard for treating ‘tranq’ wounds, but government’s help is needed
The government’s regulatory and financial support is paramount to turning the tide. Our “Philadelphia Consensus” should set the national standard for care.
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia TGA Approves NexoBrid® for Adults and ...
TipRanks on MSN
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial
Organogenesis Holdings ( ($ORGO) ) has issued an announcement. On September 25, 2025, Organogenesis Holdings announced that its second Phase 3 ...
Researchers have found in a randomized controlled clinical trial that submucosal infiltration of injectable platelet-rich ...
Main outcome measures The main outcome was the type of injuries observed by international healthcare workers during the ...
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia TGA Approves NexoBrid® for Adults and Children; Manufacturing Readiness Positions MediWound for 2025 Launch and Asia-Pa ...
Candace Smith told Newsweek: "I don't think you can effectively relay that type of experience to someone who has not felt it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback